Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-15

FDA Approved: LEVETIRACETAM — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Novadoz's original ANDA for Levetiracetam, establishing a generic anti-seizure medication. Indications include epilepsy-related seizures such as pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)